Cargando…
Cetuximab and biomarkers in non-small-cell lung carcinoma
Cancer progression is a highly complex process that is driven by a constellation of deregulated signaling pathways and key molecular events. In non-small-cell lung cancer (NSCLC), as in several other cancer types, the epidermal growth factor receptor (EGFR) and its downstream signaling components re...
Autores principales: | Patil, Nitin, Abba, Mohammed, Allgayer, Heike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421478/ https://www.ncbi.nlm.nih.gov/pubmed/22904614 http://dx.doi.org/10.2147/BTT.S24217 |
Ejemplares similares
-
MicroRNAs in the Regulation of MMPs and Metastasis
por: Abba, Mohammed, et al.
Publicado: (2014) -
MicroRNA Regulation of Epithelial to Mesenchymal Transition
por: Abba, Mohammed L., et al.
Publicado: (2016) -
Differentially expressed microRNAs in colorectal cancer metastasis
por: Abba, Mohammed, et al.
Publicado: (2015) -
miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling
por: El-Daly, Sherien M., et al.
Publicado: (2016) -
MicroRNA modulators of epigenetic regulation, the tumor microenvironment and the immune system in lung cancer
por: Rusek, Anna Maria, et al.
Publicado: (2015)